APDN Pre-Market (23 Dec 2025): Anticipating Earnings Impact
Applied DNA Sciences, Inc. (NASDAQ: APDN) is drawing attention in pre-market trading with a remarkable 31% price rise, positioning itself for exciting developments ahead of its earnings announcement on December 25, 2025.
Current Market Performance
As of the pre-market session, APDN trades at $5.62, reflecting a 31.62% increase from the previous close of $4.27. This sharp rise positions APDN significantly above its 50-day moving average of $3.55, though it remains drastically below its 200-day average of $35.61. The company’s market capitalization stands at approximately $7.3 million, with a trading volume of 2,648,596, markedly exceeding the average volume of 469,222.
Anticipated Earnings Impact
APDN is set to announce its earnings on December 25, 2025, which is critical for investors gauging its performance. Historically, Applied DNA has shown a pattern of earnings surprises. For instance, in August 2025, the EPS was markedly below estimates at -34.0 against an expectation of -22.5. This pattern instills both caution and curiosity among investors as they anticipate the upcoming quarterly report.
Technical and Fundamental Analysis
From a technical perspective, APDN has an RSI of 48.31, indicating a neutral trading position. The ADX reading of 83.91 reflects a strong trend, while the stock’s MFI of 90.58 suggests it is overbought currently. Fundamentally, the company exhibits a negative earnings yield with a PE ratio of -0.086, reflecting ongoing financial challenges. However, its current ratio of 2.76 suggests strong short-term financial health.
Meyka AI Rating and Forecast
Meyka AI rates APDN with a score of 66 out of 100, giving it a ‘B’ grade with a hold recommendation. This assessment reflects a blend of sector performance, financial growth, and key metrics. Meyka AI’s forecast model projects the stock price to reach $4.43 quarterly, presenting an implied downside risk of approximately 21% from its current price. Forecasts are model-based projections and not guarantees.
Final Thoughts
Despite historical earnings volatility and a current negative trajectory in profit metrics, APDN’s recent market activity illustrates significant volatility and potential trading opportunities. As the December 25th earnings announcement approaches, investors should be prepared for potential fluctuations. Stock prices can fluctuate based on market conditions, economic factors, and company-specific events. For detailed analysis, visit APDN.
FAQs
APDN reported a recent EPS of -34.0, falling short of the estimated -22.5. Revenue estimates have also been missed in previous quarters, illustrating ongoing fiscal challenges.
As of the pre-market session, APDN’s trading volume stands at 2,648,596, significantly above its average of 469,222, indicating heightened investor interest.
Meyka AI assigns APDN a score of 66 out of 100, with a ‘B’ grade and a hold recommendation, based on sector analysis, financial growth, and key performance metrics.
APDN’s RSI is 48.31, suggesting neutrality, while the MFI of 90.58 signals an overbought condition. The ADX is 83.91, indicating a strong trend in place.
Meyka AI forecasts a quarterly stock price of $4.43, representing a potential downside of 21% from its current pre-market price of $5.62. Forecasts are model-based projections and not guarantees.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
